-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Zheng Huzhi et al.
——Excerpt from the article chapter
【Ref: Tang M, et al.
Research background
Liposomes are small toxicity, good biocompatibility and high degradation of materials, and their amphiphilic structure can be loaded with hydrophilic and hydrophobic drugs, which is an excellent carrier
The authors create mitochondria-targeted lipid-small molecule hybrid nanoparticles (LPHNPs)
Results of the study
The results show that: (1) The mitochondria-targeted lipid-small molecule hybrid nanoparticles constructed have higher drug loading capacity and encapsulation efficiency than traditional nanoparticles (PA@liposome), and the stability of mixed nanoparticles is higherConclusion of the study
In summary, the mitochondrial-targeted hybrid nanoparticles constructed in this study have the ability to target mitochondria and fluorescence imaging, which can be used for visualization of drug distribution in vivo and imaging